Timothy Rolph

CIK 1779479 · Chief Scientific Officer · last filed 2025-12-09

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$0

Companies

1

Total Filings

47

Lifetime Open-Market Net

-$19.56M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
Akero Therapeutics, Inc. (AKRO) Delisted Chief Scientific Officer 0 $54.65 $0 -$19.56M 47 2025-12-09

Recent Filings · Page 5 of 5

47 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2022-10-04 Akero Therapeutics, Inc. (AKRO) Delisted Mixed −25,000 -$1.14M EDGAR
2022-09-15 Akero Therapeutics, Inc. (AKRO) Delisted Sell (S) −22,500 -$656.5K EDGAR
2022-09-13 Akero Therapeutics, Inc. (AKRO) Delisted Grant (A) +2,159 $30.5K EDGAR
2021-12-10 Akero Therapeutics, Inc. (AKRO) Delisted Grant (A) $0 EDGAR
2020-12-09 Akero Therapeutics, Inc. (AKRO) Delisted Grant (A) +1,245 $21.2K EDGAR
2020-03-13 Akero Therapeutics, Inc. (AKRO) Delisted Exer (M) +50,024 $30.5K EDGAR
2019-12-13 Akero Therapeutics, Inc. (AKRO) Delisted Grant (A) $0 EDGAR
Showing 4147 of 47
Page 5 of 5
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.